7.19
-1.51%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Dirui Industrial Co
Its shares trade on Shenzhen under the ticker 300396.SZ. It has been listed since 10 September 2014. In the fiscal year to 31 December 2025, it reported revenue of CN¥807.1m and a net loss of CN¥246.0m. At that date it held total assets of CN¥2.77bn and shareholders' equity of CN¥1.54bn.
Dirui Industrial Co., Ltd. engages in the research and development, production, and sale of medical testing instrument, and supporting test paper reagents. The company is headquartered in Changchun, Jilin. The company went IPO on 2014-09-10. The firm's main products include urine analysis series, urinary composition analysis series, biochemical analysis series and blood cell analysis series. The firm's products are used for routine physical examination and diagnosis of illness. The firm distributes its products in domestic market and to overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 10 Sept 2014
- Employees
- 1,879
- Website
- dirui.com.cn ↗
Leadership
Pay as last reported
- Mr. Qing SongChairman of the Board, since 2020
- Ms. Xingyan ZhangChief Financial Officer, Deputy General Manager, since 2023CN¥240,000
- Mr. Xuemin WangGeneral Manager, Director, since 2021
- Mr. Guozhu AnDeputy General Manager, Secretary of the Board, Director, since 2020
- Ms. Dandan NiuDeputy General Manager
- Mr. Bo WangDeputy General Manager
- Mr. Haitao ZhangDeputy General Manager
- Mr. Guoming ZhengDeputy General Manager, since 2019
- Mr. Maoliang LinDirector
- Mr. Bing NiDirector
- Mr. Feng QinDirector
- Mr. Mingyou AnIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Dirui Industrial Co Ltd employs 1,879 full-time employees in Changchun, China.
- Dirui's products include urine analysis and biochemical analysis series for medical diagnostics.
- Dirui distributes its products domestically in China and internationally overseas.
Weaknesses
- Dirui's headquarters city Changchun is not a major global business hub.
- Dirui's IPO date 10 September 2014 is over a decade old.
- Dirui's product range focuses on medical testing instruments without expansion into new segments.
Opportunities
- Dirui can expand its medical testing instrument sales in the growing Chinese healthcare market.
- Dirui may increase overseas market presence in Asia-Pacific regions with its diagnostic products.
- Dirui could leverage its 1,879 employees to develop new medical testing technologies.
Threats
- Dirui faces competition from established medical device companies in China's Health Care sector.
- Dirui's reliance on domestic market sales could be impacted by economic downturns in China.
- Dirui's product line lacks innovation compared to newer medical testing technologies.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.